Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-097384
Filing Date
2016-04-29
Accepted
2016-04-29 08:00:29
Documents
4
Period of Report
2016-06-14
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A v437648_def14a.htm DEF 14A 476374
2 GRAPHIC tlogo.jpg GRAPHIC 15620
3 GRAPHIC tproxy1.jpg GRAPHIC 192368
4 GRAPHIC tproxy2.jpg GRAPHIC 178736
  Complete submission text file 0001144204-16-097384.txt   1010473
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36357 | Film No.: 161602547
SIC: 2834 Pharmaceutical Preparations